Chemours Co (CC) stock
CCNYSEChemicals & Allied ProductsFiscal year ends December 31
$12.09−0.09 (-0.74%)
Close on Nov 18, 2026Market cap $1.82BP/E –Yield 4.24%
Chemours shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Chemours's shares outstanding was 151M at Jun 30, 2026. For fiscal 2025 it was 150M, up 0.0% from the year before. Over ten years it grew -1.8% a year on average. The highest annual figure on record is 191M in fiscal 2017.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 150M | +0.0% |
| FY2024 | Dec 31, 2024 | 150M | +0.8% |
| FY2023 | Dec 31, 2023 | 149M | -5.9% |
| FY2022 | Dec 31, 2022 | 158M | -6.2% |
| FY2021 | Dec 31, 2021 | 169M | +1.4% |
| FY2020 | Dec 31, 2020 | 166M | +0.9% |
| FY2019 | Dec 31, 2019 | 165M | -9.7% |
| FY2018 | Dec 31, 2018 | 183M | -4.4% |
| FY2017 | Dec 31, 2017 | 191M | +4.1% |
| FY2016 | Dec 31, 2016 | 183M | +1.3% |
| FY2015 | Dec 31, 2015 | 181M | +0.0% |
| FY2014 | Dec 31, 2014 | 181M | 0.0% |
| FY2013 | Dec 31, 2013 | 181M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 151M | +0.7% |
| Q1 FY2026 | Mar 31, 2026 | 151M | +0.6% |
| Q4 FY2025 | Dec 31, 2025 | 150M | +0.1% |
| Q3 FY2025 | Sep 30, 2025 | 151M | +0.7% |
| Q2 FY2025 | Jun 30, 2025 | 150M | +0.1% |
| Q1 FY2025 | Mar 31, 2025 | 150M | -0.1% |
| Q4 FY2024 | Dec 31, 2024 | 150M | +1.0% |
| Q3 FY2024 | Sep 30, 2024 | 150M | -0.3% |
| Q2 FY2024 | Jun 30, 2024 | 150M | +0.7% |
| Q1 FY2024 | Mar 31, 2024 | 150M | -0.7% |
| Q4 FY2023 | Dec 31, 2023 | 149M | -2.2% |
| Q3 FY2023 | Sep 30, 2023 | 150M | -4.9% |
| Q2 FY2023 | Jun 30, 2023 | 149M | -6.6% |
| Q1 FY2023 | Mar 31, 2023 | 151M | -7.6% |
| Q4 FY2022 | Dec 31, 2022 | 152M | -8.7% |
| Q3 FY2022 | Sep 30, 2022 | 158M | -6.6% |
| Q2 FY2022 | Jun 30, 2022 | 160M | -6.2% |
| Q1 FY2022 | Mar 31, 2022 | 164M | -3.2% |
| Q4 FY2021 | Dec 31, 2021 | 167M | -0.8% |
| Q3 FY2021 | Sep 30, 2021 | 169M | +1.4% |
| Q2 FY2021 | Jun 30, 2021 | 170M | +2.9% |
| Q1 FY2021 | Mar 31, 2021 | 169M | +2.3% |
| Q4 FY2020 | Dec 31, 2020 | 168M | +8.3% |
| Q3 FY2020 | Sep 30, 2020 | 167M | +0.9% |
| Q2 FY2020 | Jun 30, 2020 | 165M | -0.9% |
| Q1 FY2020 | Mar 31, 2020 | 165M | -4.0% |
| Q4 FY2019 | Dec 31, 2019 | 155M | -12.0% |
| Q3 FY2019 | Sep 30, 2019 | 165M | -9.2% |
| Q2 FY2019 | Jun 30, 2019 | 167M | -9.2% |
| Q1 FY2019 | Mar 31, 2019 | 172M | -8.6% |
| Q4 FY2018 | Dec 31, 2018 | 176M | -8.3% |
| Q3 FY2018 | Sep 30, 2018 | 182M | -5.1% |
| Q2 FY2018 | Jun 30, 2018 | 184M | -3.8% |
| Q1 FY2018 | Mar 31, 2018 | 188M | -0.4% |
| Q4 FY2017 | Dec 31, 2017 | 192M | +3.4% |
| Q3 FY2017 | Sep 30, 2017 | 192M | +4.4% |
| Q2 FY2017 | Jun 30, 2017 | 191M | – |
| Q1 FY2017 | Mar 31, 2017 | 189M | – |
| Q4 FY2016 | Dec 31, 2016 | 186M | – |
| Q3 FY2016 | Sep 30, 2016 | 184M | – |
See a number that looks wrong?